GlaxoSmithKline PLC (GSK) Given "Neutral" Rating at J P Morgan Chase & Co

GlaxoSmithKline PLC (GSK) Given "Neutral" Rating at J P Morgan Chase & Co


's stock had its "neutral" rating reiterated by research analysts at J P Morgan Chase & Co in a note issued to investors on Friday. Several other brokerages have also issued reports on GSK.



from Biotech News